Publication | Closed Access

Inhibitor of Apoptosis (IAP) survivin is indispensable for survival of HER2 gene-amplified breast cancer cells with primary resistance to HER1/2-targeted therapies

Breast OncologyOncologyMedicineCell DeathPrimary ResistanceBreast CancerHer1/2-targeted TherapiesAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyNovel TherapyTumor Biology